CapsoVision, Inc. Common Stock (CV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has a cash flow conversion efficiency ratio of -0.580x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.69 Million) by net assets ($13.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CV days of operational coverage to measure how many days the company can operate on defensive assets alone.
CapsoVision, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how CapsoVision, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CapsoVision, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ramky Infrastructure Limited
NSE:RAMKY
|
0.075x |
|
Youlchon Chem
KO:008730
|
0.029x |
|
Andes Technology Corp
TW:6533
|
-0.006x |
|
Northern Superior Resources Inc
V:SUP
|
-0.989x |
|
Zhejiang Double Arrow Rubber Co Ltd
SHE:002381
|
0.067x |
|
Shenzhen Increase Technology Co Ltd Class A
SHE:300713
|
0.057x |
|
Strattec Security Corporation
NASDAQ:STRT
|
0.043x |
|
BenQ Materials Corp
TW:8215
|
-0.005x |
Annual Cash Flow Conversion Efficiency for CapsoVision, Inc. Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of CapsoVision, Inc. Common Stock from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see CapsoVision, Inc. Common Stock stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $13.26 Million | $-22.86 Million | -1.724x | -1211.50% |
| 2024-12-31 | $-129.51 Million | $-20.09 Million | 0.155x | +57.75% |
| 2023-12-31 | $-109.84 Million | $-10.80 Million | 0.098x | -- |
About CapsoVision, Inc. Common Stock
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more